α-Conotoxin dendrimers have enhanced potency and selectivity for homomeric nicotinic acetylcholine receptors.

Covalently attached peptide dendrimers can enhance binding affinity and functional activity. Homogenous di- and tetravalent dendrimers incorporating the α7-nicotinic receptor blocker α-conotoxin ImI (α-ImI) with polyethylene glycol spacers were designed and synthesized via a copper-catalyzed azide-alkyne cycloaddition of azide-modified α-ImI to an alkyne-modified polylysine dendron. NMR and CD structural analysis confirmed that each α-ImI moiety in the dendrimers had the same 3D structure as native α-ImI. The binding of the α-ImI dendrimers to binding protein Ac-AChBP was measured by surface plasmon resonance and revealed enhanced affinity. Quantitative electrophysiology showed that α-ImI dendrimers had ∼100-fold enhanced potency at hα7 nAChRs (IC50 = 4 nM) compared to native α-ImI (IC50 = 440 nM). In contrast, no significant potency enhancement was observed at heteromeric hα3β2 and hα9α10 nAChRs. These findings indicate that multimeric ligands can significantly enhance conotoxin potency and selectivity at homomeric nicotinic ion channels.

[1]  T. Bowersock,et al.  Efficacy of a multivalent modified-live virus vaccine containing a Mannheimia haemolytica toxoid in calves challenge exposed with Bibersteinia trehalosi. , 2014, American journal of veterinary research.

[2]  Sanjiv Sonkaria,et al.  Targeting C-type lectin receptors with multivalent carbohydrate ligands. , 2013, Advanced drug delivery reviews.

[3]  R. Koenen,et al.  Incorporation of disulfide containing protein modules into multivalent antigenic conjugates: generation of antibodies against the thrombin-sensitive region of murine protein S. , 2012, Journal of the American Chemical Society.

[4]  J. Reymond,et al.  Peptide and glycopeptide dendrimer apple trees as enzyme models and for biomedical applications. , 2012, Organic & biomolecular chemistry.

[5]  L. Josephson,et al.  Hybrid peptide dendrimers for imaging of chemokine receptor 4 (CXCR4) expression. , 2011, Molecular pharmaceutics.

[6]  Tongwen Xu,et al.  Design of biocompatible dendrimers for cancer diagnosis and therapy: current status and future perspectives. , 2011, Chemical Society reviews.

[7]  Jason E Hein,et al.  Copper-catalyzed azide-alkyne cycloaddition (CuAAC) and beyond: new reactivity of copper(I) acetylides. , 2010, Chemical Society reviews.

[8]  P. Heegaard,et al.  Dendrimers for vaccine and immunostimulatory uses. A review. , 2010, Bioconjugate chemistry.

[9]  Jacobson,et al.  Polyamidoamine (PAMAM) dendrimer conjugates of "clickable" agonists of the A3 adenosine receptor and coactivation of the P2Y14 receptor by a tethered nucleotide. , 2010, Bioconjugate chemistry.

[10]  Richard A Houghten,et al.  A Synthetic Combinatorial Strategy for Developing α-Conotoxin Analogs as Potent α7 Nicotinic Acetylcholine Receptor Antagonists* , 2009, The Journal of Biological Chemistry.

[11]  F. Veronese,et al.  PEGylation of proteins as tailored chemistry for optimized bioconjugates , 2006 .

[12]  E. Giralt,et al.  Peptide and amide bond-containing dendrimers. , 2005, Chemical reviews.

[13]  S. Sine,et al.  α-Conotoxins ImI and ImII target distinct regions of the human α7 nicotinic acetylcholine receptor and distinguish human nicotinic receptor subtypes , 2004 .

[14]  Robert J Gillies,et al.  Hitting multiple targets with multimeric ligands , 2004, Expert opinion on therapeutic targets.

[15]  R. Lewis,et al.  Alpha-conotoxins as tools for the elucidation of structure and function of neuronal nicotinic acetylcholine receptor subtypes. , 2004, European journal of biochemistry.

[16]  Morten Meldal,et al.  Peptidotriazoles on solid phase: [1,2,3]-triazoles by regiospecific copper(i)-catalyzed 1,3-dipolar cycloadditions of terminal alkynes to azides. , 2002, The Journal of organic chemistry.

[17]  T. Sixma,et al.  A glia-derived acetylcholine-binding protein that modulates synaptic transmission , 2001, Nature.

[18]  J. Tam,et al.  Synthesis of Peptide Dendrimer , 1994 .

[19]  J. Tam,et al.  Synthetic peptide vaccine design: synthesis and properties of a high-density multiple antigenic peptide system. , 1988, Proceedings of the National Academy of Sciences of the United States of America.